Alzheimer’s screening bill advances in House committee: what families should know
Updated: Sep 26
News · Source and committee vote: September 16, 2026 · Website publication: September 21, 2026
The Alzheimer’s Association reports that the House Ways and Means Committee unanimously advanced the Alzheimer’s Screening and Prevention (ASAP) Act on September 16. The proposal would open a pathway for Medicare to consider coverage of early Alzheimer’s screening tests through its evidence-based review process.
What this vote means
This is a legislative step—not a new Medicare benefit. The committee vote itself does not make a screening test covered, and the proposal is not an automatic coverage mandate.
Why it matters for families and caregivers
For families following developments in dementia care, the distinction between a promising headline and an available service matters. A proposal about future coverage does not answer whether a particular test is appropriate or covered for someone today.
Our practical takeaway: bring questions about memory changes or testing to the person’s clinician. Before scheduling a test, ask the provider and health plan about current coverage and possible out-of-pocket costs. Include the person receiving care in those conversations.
